Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson's tremor
- PMID: 31509182
- DOI: 10.1093/brain/awz261
Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson's tremor
Abstract
Rest tremor in Parkinson's disease is related to cerebral activity in both the basal ganglia and a cerebello-thalamo-cortical circuit. Clinically, there is strong interindividual variation in the therapeutic response of tremor to dopaminergic medication. This observation casts doubt on the idea that Parkinson's tremor has a dopaminergic basis. An interesting alternative explanation is that interindividual differences in the pathophysiology of tremor may underlie this clinical heterogeneity. Previous work showed that dopaminergic medication reduces Parkinson's tremor by inhibiting tremulous activity in the pallidum and thalamus, and this may explain why some tremors are dopamine-responsive. Here we test the hypothesis that dopamine-resistant resting tremor may be explained by increased contributions of non-dopaminergic brain regions, such as the cerebellum. To test this hypothesis, we first performed a levodopa challenge test in 83 tremulous Parkinson's disease patients, and selected 20 patients with a markedly dopamine-responsive tremor (71% reduction) and 14 patients with a markedly dopamine-resistant tremor (6% reduction). The dopamine response of other core motor symptoms was matched between groups. Next, in all 34 patients, we used combined EMG-functional MRI to quantify tremor-related brain activity during two separate sessions (crossover, double-blind, counterbalanced design): after placebo, or after 200/50 mg dispersible levodopa/benserazide. We compared tremor-related brain activity between groups and medication sessions. Both groups showed tremor amplitude-related brain activity in a cerebello-thalamo-cortical circuit. Dopamine-resistant tremor patients showed increased tremor-related activity in non-dopaminergic areas (cerebellum), whereas the dopamine-responsive group showed increased tremor-related activity in the thalamus and secondary somatosensory cortex (across medication sessions). Levodopa inhibited tremor-related thalamic responses in both groups, but this effect was significantly greater in dopamine-responsive patients. These results suggest that dopamine-resistant tremor may be explained by increased cerebellar and reduced somatosensory influences onto the cerebellar thalamus, making this region less susceptible to the inhibitory effects of dopamine.
Keywords: Parkinson’s disease; epidemiology; imaging; neurophysiology; tremor.
© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Dopamine controls Parkinson's tremor by inhibiting the cerebellar thalamus.Brain. 2017 Mar 1;140(3):721-734. doi: 10.1093/brain/aww331. Brain. 2017. PMID: 28073788
-
The Cerebral Network of Parkinson's Tremor: An Effective Connectivity fMRI Study.J Neurosci. 2016 May 11;36(19):5362-72. doi: 10.1523/JNEUROSCI.3634-15.2016. J Neurosci. 2016. PMID: 27170132 Free PMC article.
-
Cognitive load amplifies Parkinson's tremor through excitatory network influences onto the thalamus.Brain. 2020 May 1;143(5):1498-1511. doi: 10.1093/brain/awaa083. Brain. 2020. PMID: 32355951
-
Tremor pathophysiology: lessons from neuroimaging.Curr Opin Neurol. 2020 Aug;33(4):474-481. doi: 10.1097/WCO.0000000000000829. Curr Opin Neurol. 2020. PMID: 32657888 Review.
-
Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?Brain. 2012 Nov;135(Pt 11):3206-26. doi: 10.1093/brain/aws023. Epub 2012 Mar 1. Brain. 2012. PMID: 22382359 Free PMC article. Review.
Cited by
-
A review on pathology, mechanism, and therapy for cerebellum and tremor in Parkinson's disease.NPJ Parkinsons Dis. 2022 Jun 24;8(1):82. doi: 10.1038/s41531-022-00347-2. NPJ Parkinsons Dis. 2022. PMID: 35750692 Free PMC article. Review.
-
Linking the cerebellum to Parkinson disease: an update.Nat Rev Neurol. 2023 Nov;19(11):645-654. doi: 10.1038/s41582-023-00874-3. Epub 2023 Sep 26. Nat Rev Neurol. 2023. PMID: 37752351 Review.
-
Integrative Brain States Facilitate the Expression of Parkinson's Tremor.Mov Disord. 2023 Sep;38(9):1615-1624. doi: 10.1002/mds.29506. Epub 2023 Jun 26. Mov Disord. 2023. PMID: 37363818 Free PMC article.
-
Clinical and Kinematic Features of Valproate-Induced Tremor and Differences with Essential Tremor.Cerebellum. 2021 Jun;20(3):374-383. doi: 10.1007/s12311-020-01216-5. Epub 2020 Nov 16. Cerebellum. 2021. PMID: 33200286 Free PMC article.
-
Propranolol Reduces Parkinson's Tremor and Inhibits Tremor-Related Activity in the Motor Cortex: A Placebo-Controlled Crossover Trial.Ann Neurol. 2025 Apr;97(4):741-752. doi: 10.1002/ana.27159. Epub 2024 Dec 21. Ann Neurol. 2025. PMID: 39707791 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical